rs949170696
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BS1_SupportingBS2
The NM_021098.3(CACNA1H):c.3974G>A(p.Arg1325Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,608,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1325W) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.3935G>A | p.Arg1312Gln | missense_variant | Exon 20 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.3935G>A | p.Arg1312Gln | missense_variant | Exon 20 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.3974G>A | p.Arg1325Gln | missense_variant | Exon 20 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.4024G>A | non_coding_transcript_exon_variant | Exon 20 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*1887G>A | non_coding_transcript_exon_variant | Exon 20 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*3421G>A | non_coding_transcript_exon_variant | Exon 19 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.3974G>A | non_coding_transcript_exon_variant | Exon 20 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000640028.1 | n.*1887G>A | 3_prime_UTR_variant | Exon 20 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*3421G>A | 3_prime_UTR_variant | Exon 19 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152128Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000164 AC: 4AN: 244642 AF XY: 0.0000225 show subpopulations
GnomAD4 exome AF: 0.0000172 AC: 25AN: 1456706Hom.: 0 Cov.: 40 AF XY: 0.0000179 AC XY: 13AN XY: 724746 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152128Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74296 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1325 of the CACNA1H protein (p.Arg1325Gln). This variant is present in population databases (no rsID available, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 529613). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNA1H protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at